APEX1 and acute myeloid leukemia: Further, the AML sample (AML#9) most insensitive towards APE1 inhibitor III (IC50 5781 nM) was DNMT3A-, FLT3-TKD-, IDH1-, NPM1-, NRAS-mutated and harbored a normal karyotype.